When Drug Cost-Sharing Increases, Patients Newly Diagnosed with a Chronic Illness Delay Starting Medication

Publication Date: January 2009

Publisher: RAND Corporation

Author(s): Matthew D. Solomon; Dana P. Goldman; Geoffrey F. Joyce; Jose J. Escarce

Research Area:

Type: Brief


Describes a study showing that increasing copayments for prescription drugs causes patients newly diagnosed with hypertension, high cholesterol, and diabetes to delay starting treatment, which in turn increases their risk for heart attack and stroke.